Literature DB >> 12919314

Uptake and metabolism of [3H]anandamide by rabbit platelets. Lack of transporter?

Lambrini Fasia1, Vivi Karava, Athanassia Siafaka-Kapadai.   

Abstract

Anandamide is an endogenous ligand for cannabinoid receptor and its protein-mediated transport across cellular membranes has been demonstrated in cells derived from brain as well as in cells of the immune system. This lipid is inactivated via intracellular degradation by a fatty acid amidohydrolase (FAAH). In the present study, we report that rabbit platelets, in contrast to human platelets, do not possess a carrier-mediated mechanism for the transport of [3H]anandamide into the cell, i.e. cellular uptake was not temperature dependent and its accumulation was not saturable. This endocannabinoid appears to enter the cell by simple diffusion. Once taken up by rabbit platelets, [3H]anandamide was rapidly metabolized into compounds which were secreted into the medium. Small amounts of free arachidonic acid as well as phospholipids were amongst the metabolic products. FAAH inhibitors did not decrease anandamide uptake, whereas these compounds inhibited anandamide metabolism. In conclusion, anandamide is rapidly taken up by rabbit platelets and metabolized mainly into water-soluble metabolites. Interestingly, the present study also suggests the absence of a transporter for anandamide in these cells.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12919314     DOI: 10.1046/j.1432-1033.2003.03724.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  10 in total

1.  Pitfalls and solutions in assaying anandamide transport in cells.

Authors:  Sergio Oddi; Filomena Fezza; Giuseppina Catanzaro; Chiara De Simone; Mariangela Pucci; Daniele Piomelli; Alessandro Finazzi-Agrò; Mauro Maccarrone
Journal:  J Lipid Res       Date:  2010-05-06       Impact factor: 5.922

Review 2.  Endocannabinoids and the haematological system.

Authors:  M D Randall
Journal:  Br J Pharmacol       Date:  2007-08-20       Impact factor: 8.739

3.  Evidence for bidirectional endocannabinoid transport across cell membranes.

Authors:  Andrea Chicca; Janine Marazzi; Simon Nicolussi; Jürg Gertsch
Journal:  J Biol Chem       Date:  2012-08-09       Impact factor: 5.157

4.  Fatty acid-binding proteins transport N-acylethanolamines to nuclear receptors and are targets of endocannabinoid transport inhibitors.

Authors:  Martin Kaczocha; Stephanie Vivieca; Jing Sun; Sherrye T Glaser; Dale G Deutsch
Journal:  J Biol Chem       Date:  2011-12-14       Impact factor: 5.157

Review 5.  Endocannabinoids at the synapse and beyond: implications for neuropsychiatric disease pathophysiology and treatment.

Authors:  Andrew Scheyer; Farhana Yasmin; Saptarnab Naskar; Sachin Patel
Journal:  Neuropsychopharmacology       Date:  2022-09-13       Impact factor: 8.294

6.  Characterization of an anandamide degradation system in prostate epithelial PC-3 cells: synthesis of new transporter inhibitors as tools for this study.

Authors:  Lidia Ruiz-Llorente; Silvia Ortega-Gutiérrez; Alma Viso; María G Sánchez; Ana M Sánchez; Carlos Fernández; José A Ramos; Cecilia Hillard; Miguel A Lasunción; María L López-Rodríguez; Inés Díaz-Laviada
Journal:  Br J Pharmacol       Date:  2004-01-12       Impact factor: 8.739

7.  Further evidence for the existence of a specific process for the membrane transport of anandamide.

Authors:  Alessia Ligresti; Enrico Morera; Mario Van Der Stelt; Krisztina Monory; Beat Lutz; Giorgio Ortar; Vincenzo Di Marzo
Journal:  Biochem J       Date:  2004-05-15       Impact factor: 3.857

8.  Anandamide externally added to lipid vesicles containing trapped fatty acid amide hydrolase (FAAH) is readily hydrolyzed in a sterol-modulated fashion.

Authors:  Martin Kaczocha; Qingqing Lin; Lindsay D Nelson; Michelle K McKinney; Benjamin F Cravatt; Erwin London; Dale G Deutsch
Journal:  ACS Chem Neurosci       Date:  2012-01-18       Impact factor: 4.418

9.  Identification of intracellular carriers for the endocannabinoid anandamide.

Authors:  Martin Kaczocha; Sherrye T Glaser; Dale G Deutsch
Journal:  Proc Natl Acad Sci U S A       Date:  2009-03-23       Impact factor: 11.205

Review 10.  Mechanisms of endocannabinoid transport in the brain.

Authors:  Martin Kaczocha; Samir Haj-Dahmane
Journal:  Br J Pharmacol       Date:  2021-05-27       Impact factor: 9.473

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.